Chief Executive Officer

Pseudotumor Cerebri Market Size, Share & Trends | USD 4.01 Bn in 2024 to USD 6.62 Bn by 2032

Sobi’s NASP filing accepted by FDA in uncontrolled gout

FDA Accepts Biologics License Application for Sobi's NASP for Patients with Uncontrolled Gout

Sobi's Application for New Gout Drug Accepted by US FDA

Executive Director, Financial Planning and Analysis

Sobi - Swedish Orphan Biovitrum AB is dedicated to developing innovative therapies for rare diseases. They are seeking an Executive Director of Financial Planning and Analysis who will lead the financial planning, budgeting, and strategic analysis functions, serving as a key advisor to senior leadership to drive key investments and profitability.

Sign up with Google

Sign in with Google